5 Insightful Analyst Questions From Flowserve's Q4 Earnings Call
Flowserve’s fourth quarter performance garnered a positive market reaction, as the company reported continued momentum in its aftermarket segment and highlighted progress on operational improvements. Management credited strong aftermarket bookings and growth in power and nuclear end markets as key drivers, while original equipment sales faced temporary delays due to customer and material timing issues. CEO Robert Rowe emphasized the resilience added by the company’s diversified portfolio and noted, “Our 3D diversification strategy has made Flowserve more cycle-resilient than ever before.”
Is now the time to buy FLS?
Flowserve (FLS) Q4 CY2025 Highlights:
- Revenue: $1.22 billion vs analyst estimates of $1.27 billion (3.5% year-on-year growth, 3.5% miss)
- Adjusted EPS: $1.11 vs analyst estimates of $0.94 (18.4% beat)
- Adjusted EBITDA: $228.3 million vs analyst estimates of $206.7 million (18.7% margin, 10.5% beat)
- Adjusted EPS guidance for the upcoming financial year 2026 is $4.10 at the midpoint, beating analyst estimates by 2.6%
- Operating Margin: 3.5%, down from 10.6% in the same quarter last year
- Backlog: $2.87 billion at quarter end, up 2.8% year on year
- Market Capitalization: $10.99 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Flowserve’s Q4 Earnings Call
- Deane Dray (RBC Capital Markets) asked about the light organic revenue growth and project timing. CFO Amy Schwetz explained that customer delays and timing of material receipts pushed some project revenues into the first half of next year, but expects these to normalize.
- Michael Halloran (Baird) inquired about confidence in mid-single-digit order growth. CEO Robert Rowe highlighted strong aftermarket momentum and expected acceleration in Middle East and power sector spending as key drivers.
- Amit Mehrotra (UBS) questioned the structural growth implied in the 2030 outlook. Rowe and Schwetz pointed to nuclear and power tailwinds, commercial excellence initiatives, and backlog conversion as supporting factors for long-term growth.
- Joseph Giordano (TD Cowen) probed the dependence of margin expansion on volume growth. Rowe stated margin improvements are achievable through operational gains and mix even with modest revenue growth, citing past success.
- Brett Linzey (Mizuho) asked about delays in procurement and the increased nuclear content opportunity from Trillium Valves. Schwetz clarified supply chain delays were not structural, while Rowe detailed how Trillium expands content per new nuclear reactor.
Catalysts in Upcoming Quarters
In upcoming quarters, our analysts will watch (1) the pace at which Flowserve converts its record nuclear and power backlog into revenue, (2) the sustainability of aftermarket growth and its margin contribution, and (3) the effectiveness of Trillium Valves integration in expanding the company’s presence in high-margin sectors. Execution on operational efficiency and the ability to navigate ongoing supply chain and tariff challenges will also be key factors.
Flowserve currently trades at $86.63, up from $78.98 just before the earnings. In the wake of this quarter, is it a buy or sell?
High-Quality Stocks for All Market Conditions
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Federal Reserve approves stress test reform by a 6-1 vote: Capital requirement volatility halved, sole dissenting vote warns of reduced resilience
The Federal Reserve has officially approved two final rules aimed at increasing transparency and reducing capital requirement volatility by approximately 50%. The new regulations will seek public comments on stress test scenarios and will calculate the capital buffer based on the average of the results from two consecutive years of testing. This averaging mechanism will take effect in 2028. The reforms are the result of years of negotiation within the banking sector and have been welcomed by industry groups. However, critics such as Governor Barr warn that the reforms will weaken the constraints of stress testing and reduce the overall resilience of the banking system.

Metals fade as long yields offset cooler inflation, lower Fed odds - Kitco PM Report
Bitwise brings NEAR to Wall Street – But the chart isn’t impressed
Synopsys and OpenAI reach AI chip design partnership, stock price surges over 7%
Synopsys has signed a multi-year legally binding agreement with OpenAI to jointly develop GPT-Synopsys, a model specifically trained and fine-tuned for chip design tasks. OpenAI will pay Synopsys a subscription fee for tool licensing, and both parties will share revenue based on improvements in chip design achieved by customers using the product.
